Skip to content
BioNews Central
  • Home
  • Biomedical Advances
  • Diet & Lifestyle
  • Preventive Medicine
  • COVID-19
  • Quizzes

Posts Tagged ‘severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)’

Interleukin-33 involved in SARS-CoV-2 immunity

Max-Planck-Gesellschaft | 04-09-2021

New study links the production of cytokine interleukin 33 to SARS-CoV-2 immunity, which could have implications for future COVID-19 therapies. …

Read Full Article

COVID-19 causes unexpected cellular response in the lungs

Purdue University | 04-08-2021

A biochemical pathway, known as the immune complement system, is unexpectedly triggered in lung cells by SARS-CoV-2, which might explain why COVID-19 is so difficult to treat. …

Read Full Article

One in ten have long-term effects 8 months following mild COVID-19

Karolinska Institutet | 04-07-2021

Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom with an impact on quality of life. …

Read Full Article

COVID-19 survivors might need just one dose of two-part vaccine

Cedars-Sinai Medical Center | 04-01-2021

A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence …

Read Full Article

B.1.1.7 variant of COVID-19 spreading rapidly in United States

Scripps Research Institute | 03-31-2021

Genetic analysis of coronavirus samples suggests the UK-originating variant of COVID-19, which is 40-50 percent more transmissible, entered the US in late November 2020. …

Read Full Article

Anti-inflammatory drug protects against lethal inflammation from COVID-19 in animal models

Mount Sinai Hospital/Mount Sinai School of Medicine | 03-30-2021

A widely available and inexpensive anti-inflammatory drug, topotecan, reduced morbidity and mortality in mice infected with SARS-CoV-2. …

Read Full Article

T cells recognize recent SARS-CoV-2 variants

NIH-NIAID | 03-30-2021

New research suggests T-cells from recovered COVID-19 patients recognize the major SARS-CoV-2 variants. …

Read Full Article

Evidence for reduced antibody protection against SARS-CoV-2 variants

DPZ | 03-25-2021

Cell culture studies show that SARS-CoV-2 variants are less susceptible to inhibition by antibodies from recovered or vaccinated individuals. …

Read Full Article

SARS-CoV-2 infection of mouth cells: Potential role of saliva in viral transmission

University of North Carolina at Chapel Hill | 03-25-2021

New research shows the mouth is an important site for SARS-CoV-2 infection and saliva is a potential route of viral transmission. …

Read Full Article

COVID-19 vaccines may not produce sufficient antibody response in transplant recipients

Johns Hopkins University | 03-24-2021

Immunocompromised transplant recipients who received their first dose of COVID-19 mRNA vaccine show poor immunogenic response as only 17 percent produced detectable SARS-CoV-2 antibodies. …

Read Full Article
Older Posts »

Popular Tags

aging alzheimer's disease brain and cognitive health cancer cardiovascular disease coronavirus COVID-19 diabetes diet immune cells immune response immune system inflammation microbiome mouse study neurons obesity SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cells

About           Terms          Copyright          Privacy          Contact

About

Terms

Copyright

Privacy

Contact

© 2021 BioNews Central  |  Bright Quest Media  |  All Rights Reserved

Scroll To Top